Department of Human Movement Sciences, Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, Amsterdam, The Netherlands.
Department of Clinical Chemistry, Laboratory Medical Immunology, Amsterdam UMC, Location VU Medical Centre, Amsterdam, The Netherlands.
Pain Med. 2021 Nov 26;22(11):2661-2669. doi: 10.1093/pm/pnab243.
OBJECTIVE: The association between low-grade systemic inflammation and musculoskeletal pain may be influenced by multiple factors. However, little is known about the relative importance of these factors, and few studies account for them. This Delphi study aimed to reach consensus on the most important confounders which influence the association between low-grade systemic inflammation and musculoskeletal pain. METHODS: The panel consisted of 48 experts. In Round 1, the experts proposed what they believed were important confounders. In Round 2, the experts indicated for each confounder whether they believed it was important (yes/no). At least 50% of experts had to indicate the confounder was important to be considered in the final round. In Round 3, the experts rated the importance of each confounder on a 7-point Likert scale. Consensus was reached if ≥75% of the experts considered the factor either extremely or moderately important. RESULTS: In Round 1, 120 confounders were proposed, which were synthesized into 38 distinct factors. In Round 2, 33 confounders met the criterion to be considered important. In Round 3, consensus was reached for 14 confounders: acute illness/trauma, immune disease, medication use, endocrine, nutritional, or metabolic disease, other musculoskeletal conditions, age, handling of blood samples, sex, cancer, body composition, pregnancy, cardiovascular disease, physical activity, and pain characteristics. CONCLUSIONS: These findings provide insight in the complexity of the association between low-grade systemic inflammation and musculoskeletal pain. Some factors currently listed as confounders may be re-classified as moderators or mediators as insights progress.
目的:低水平系统性炎症与肌肉骨骼疼痛之间的关联可能受到多种因素的影响。然而,人们对这些因素的相对重要性知之甚少,而且很少有研究考虑到这些因素。本德尔菲研究旨在就影响低水平系统性炎症与肌肉骨骼疼痛之间关联的最重要混杂因素达成共识。
方法:该小组由 48 名专家组成。在第 1 轮中,专家们提出了他们认为重要的混杂因素。在第 2 轮中,专家们对每个混杂因素表示他们是否认为这很重要(是/否)。至少 50%的专家必须表示混杂因素很重要,才能进入最后一轮。在第 3 轮中,专家们对每个混杂因素的重要性进行了 7 级李克特量表评分。如果≥75%的专家认为该因素非常重要或中等重要,则达成共识。
结果:在第 1 轮中,提出了 120 个混杂因素,将其综合为 38 个不同的因素。在第 2 轮中,有 33 个混杂因素符合重要性标准。在第 3 轮中,有 14 个混杂因素达成共识:急性疾病/创伤、免疫性疾病、药物使用、内分泌、营养或代谢性疾病、其他肌肉骨骼疾病、年龄、血液样本处理、性别、癌症、身体成分、怀孕、心血管疾病、身体活动和疼痛特征。
结论:这些发现为低水平系统性炎症与肌肉骨骼疼痛之间的关联的复杂性提供了深入了解。随着研究的进展,一些目前被列为混杂因素的因素可能会被重新归类为调节剂或中介物。
Afr J Prim Health Care Fam Med. 2023-4-25
BMC Musculoskelet Disord. 2020-9-8
Brain Behav Immun Health. 2024-11-9
Aging Clin Exp Res. 2023-8
Pain Manag Nurs. 2023-2
BMC Musculoskelet Disord. 2020-3-3
Curr Rheumatol Rep. 2019-12-5
Nat Commun. 2019-10-25